0001161697-20-000126.txt : 20200320 0001161697-20-000126.hdr.sgml : 20200320 20200319180431 ACCESSION NUMBER: 0001161697-20-000126 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200319 ITEM INFORMATION: Changes in Registrant's Certifying Accountant FILED AS OF DATE: 20200320 DATE AS OF CHANGE: 20200319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: StemGen, Inc. CENTRAL INDEX KEY: 0001023198 STANDARD INDUSTRIAL CLASSIFICATION: INVESTORS, NEC [6799] IRS NUMBER: 541812385 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-21555 FILM NUMBER: 20729706 BUSINESS ADDRESS: STREET 1: 1 PERFORMANCE DRIVE, SUITE F CITY: ANGLETON STATE: TX ZIP: 77515 BUSINESS PHONE: 832-954-7569 MAIL ADDRESS: STREET 1: 1 PERFORMANCE DRIVE, SUITE F CITY: ANGLETON STATE: TX ZIP: 77515 FORMER COMPANY: FORMER CONFORMED NAME: AMASYS CORP DATE OF NAME CHANGE: 19960918 8-K 1 form_8-k.htm FORM 8-K CURRENT REPORT FOR 03-19-2020

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT


Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report (Date of earliest event reported):  March 19, 2020


STEMGEN, INC.

(Exact name of Registrant as specified in charter)


Delaware

0-21555

54-1812385

(State of Other Jurisdiction

of Incorporation)

(Commission

File Number)

(IRS Employer

Identification No.)


1 Performance Drive, Suite F

 

Angleton, Texas

77515

(Address of Principal Executive Offices)

(Zip Code)


(832) 954-7569

Registrant’s telephone number, including area code


 

(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


[  ]

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

[  ]

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

[  ]

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

[  ]

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:  None.


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).


Emerging growth company [  ]             


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]



Item 4.01 Changes in Registrant’s Certifying Accountant.


(b)     Appointment of new independent registered public accounting firm.


On March 19, 2020, the Board of Directors of StemGen, Inc. (the “Company”) approved the appointment of PWR CPA, LLP (“PWR”) as the Company’s new independent registered public accounting firm.


In connection with the Company’s appointment of PWR as the Company’s independent registered public accounting firm, the Company has not consulted PWR on any matter relating to either (i) the application of accounting principles to a specific transaction, either completed or contemplated, or the type of audit opinion that might be rendered on the Company’s financial statements or (ii) any matter that was the subject of a disagreement (as that term is defined in Item 304(a)(1)(iv) of Regulation S-K and the related instructions) or a “reportable event” (as that term is defined in Item 304(a)(1)(v) of Regulation S-K).



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

STEMGEN, INC.

 

 

 

 

Dated:  March 19, 2020

/s/ Simon Dawson

 

Simon Dawson

 

Chief Executive Officer


- 2 -